Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of Rebamipide on gastritis after ERCP for choledocholithiasis (pilot study)
KCT0008550Phase 4Not yet recruiting
- Sponsor
- Korea Otsuka Pharmaceutical
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of rebamipide in gastritis, sponsored by Korea Otsuka Pharmaceutical. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
rebamipide
03
Conditions
gastritis
Beyond the preview
Go deeper on KCT0008550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008550.